Compare Live Nation Entertainment, Inc. (LYV) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Live Nation Entertainment, Inc. vs Recursion Pharmaceuticals Inc — how do they compare? Live Nation Entertainment, Inc. trades at $185.35 (market cap $42.71B), while Recursion Pharmaceuticals Inc trades at $3.34 (market cap $1.81B). The key difference: Live Nation Entertainment, Inc. is far larger — about 23.6× Recursion Pharmaceuticals Inc's market cap, and Live Nation Entertainment, Inc. is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| LYV | RXRX | |
|---|---|---|
Market Cap | $42.71B | $1.81B |
Sector | Industrials | Health |
52-Week High | $186.59 | $6.79 |
52-Week Low | $125.61 | $2.84 |
Enterprise Value | $44.92B | $1.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LYV trades at $184.64, up 2.2% on the day, with a bullish technical signal from moving averages and strong analyst support (86.96% buy ratings). The company reported Q2 2026 EPS of $1.05, beating estimates, and revenue growth driven by record concert demand. However, valuation metrics like a P/E of 117.49 and negative ROE of -116.65% highlight significant premium pricing and profitability challenges.
Outlook remains positive due to robust live event demand and raised full-year expectations, but risks include high debt, legal uncertainties, and margin pressure. The consensus price target of $209.54 suggests ~13.5% upside, though investors should weigh growth potential against elevated valuation and operational risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
